Skip to main content
Fig. 3 | Diabetology & Metabolic Syndrome

Fig. 3

From: Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial

Fig. 3

Primary endpoints. a Rate pressure product at 0.1 mV ST-segment depression ETT-1 placebo vs. ETT-3 1.2 mg liraglutide. b Rate pressure product at 0.1 mV ST-segment depression ETT-2 placebo vs. ETT-4 1.8 mg liraglutide. c ST-segment depression at peak exercise ETT-1 placebo vs. ETT-3 1.2 mg liraglutide. d ST-segment depression at peak exercise ETT-2 placebo vs. ETT-4 1.8 mg liraglutide

Back to article page